181 related articles for article (PubMed ID: 32851536)
1. The role of EP-2 receptor expression in cervical intraepithelial neoplasia.
Schmoeckel E; Fraungruber P; Kuhn C; Jeschke U; Mahner S; Kolben TM; Kolben T; Vilsmaier T; Hester A; Heidegger HH
Histochem Cell Biol; 2020 Dec; 154(6):655-662. PubMed ID: 32851536
[TBL] [Abstract][Full Text] [Related]
2. The role of EP3-receptor expression in cervical dysplasia.
Hester A; Ritzer M; Kuhn C; Schmoeckel E; Mayr D; Kolben T; Dannecker C; Mahner S; Jeschke U; Kolben TM
J Cancer Res Clin Oncol; 2019 Feb; 145(2):313-319. PubMed ID: 30402741
[TBL] [Abstract][Full Text] [Related]
3. The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases.
Dietlmeier S; Ye Y; Kuhn C; Vattai A; Vilsmaier T; Schröder L; Kost BP; Gallwas J; Jeschke U; Mahner S; Heidegger HH
Sci Rep; 2020 Jan; 10(1):1154. PubMed ID: 31980713
[TBL] [Abstract][Full Text] [Related]
4. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Hester A; Temelkov M; Heidegger H; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):377-386. PubMed ID: 34739585
[TBL] [Abstract][Full Text] [Related]
5. BAG3 expression correlates with the grade of dysplasia in squamous intraepithelial lesions of the uterine cervix.
Raffone A; Travaglino A; D'Antonio A; De Marco M; Caccese M; Mascolo M; Insabato L; Zeppa P; Rosati A; Mollo A; Zullo F; Guida M
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):99-104. PubMed ID: 31444794
[TBL] [Abstract][Full Text] [Related]
6. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
7. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
8. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
9. Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.
Vogelsang TLR; Schmoeckel E; Kuhn C; Blankenstein T; Temelkov M; Heidegger H; Kolben TM; Kolben T; Mahner S; Mayr D; Jeschke U; Vattai A
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1847-1855. PubMed ID: 32157438
[TBL] [Abstract][Full Text] [Related]
10. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Expression of the Cell Polarity Regulator aPKCλ/ι is Associated With Disease Progression in Cervical Intraepithelial Neoplasia (CIN): A Possible Marker for Predicting CIN Prognosis.
Mizushima T; Asai-Sato M; Akimoto K; Nagashima Y; Taguri M; Sasaki K; Nakaya MA; Asano R; Tokinaga A; Kiyono T; Hirahara F; Ohno S; Miyagi E
Int J Gynecol Pathol; 2016 Mar; 35(2):106-17. PubMed ID: 26535980
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression.
Gupta R; Srinivasan R; Nijhawan R; Suri V
Virchows Arch; 2010 Jan; 456(1):45-51. PubMed ID: 19937343
[TBL] [Abstract][Full Text] [Related]
13. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
14. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
15. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Int J Gynecol Pathol; 2008 Apr; 27(2):265-73. PubMed ID: 18317213
[TBL] [Abstract][Full Text] [Related]
16. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations.
Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE
Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
Wang HR; Liao GD; Jiang Y; Li YC; Qiao YL; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1241-1245. PubMed ID: 28910940
[No Abstract] [Full Text] [Related]
18. Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.
DE Lima TM; DE Azevedo Focchi GR; DE Almeida BC; Belfort-Mattos PN; Heinke T; DE Góis Speck NM
Anticancer Res; 2018 Dec; 38(12):6673-6681. PubMed ID: 30504376
[TBL] [Abstract][Full Text] [Related]
19. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
20. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
